Literature DB >> 5778788

Studies on human antibodies. 8. Properties and association constants of human antibodies to blood group A substance purified with insoluble specific adsorbents and fractionally fluted with mono- and oligosaccharide.

C Moreno, E A Kabat.   

Abstract

Human antibodies to blood group A substance were purified by absorption on columns of insoluble polyleucyl hog blood group A + H substance and eluted first with N-acetylgalactosamine and then with an A active reduced pentasaccharide AR(L)0.52. The gammaM and gammaG antibodies in these eluates were separated by density gradient centrifugation. The antibodies were studied for their relative capacities to be inhibited by various blood group A active oligosaccharides. Antibodies eluted by the N-acetylgalactosamine could be inhibited by N-acetylgalactosamine, as well as by lower concentrations of A active tri- and pentasaccharides, while those eluted by the pentasaccharide AR(L)0.52 could only be inhibited by the two oligosaccharides, but not by N-acetylgalactosamine, indicating that the N-acetylgalactosamine eluate had more antibodies with smaller size combining sites than the AR(L)0.52 eluate. Measurements by equilibrium dialysis gave values ranging from 2 x 10(3) to 1 x 10(5)M(-1) and the values obtained with the AR(L)0.52 eluate were somewhat higher than those with the GalNAc eluate. Only one of three anti-A sera had gammaM anti-A in the AR(L)0.52 eluate, while all three had gammaM in the N-acetylgalactosamine eluate. Data on the precipitating, hemagglutinating, complement fixing, hemolytic properties of the eluted antibodies, and of their content of kappa and lambda light chains are given.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5778788      PMCID: PMC2138645          DOI: 10.1084/jem.129.5.871

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  SPECIFIC FRACTIONATION OF HUMAN ANTI-DEXTRAN ANTIBODIES. 3. FRACTIONATION OF ANTI-DEXTRAN BY SEQUENTIAL EXTRACTION WITH OLIGOSACCHRIDES OF INCREASING CHAIN LENGTH AND ATTEMPTS AT SUBFRACTIONATION.

Authors:  J GELZER; E A KABAT
Journal:  Immunochemistry       Date:  1964-12

2.  Separation of 6.6S and 18S gamma globulins with isohemagglutinin activity.

Authors:  J L FAHEY; E G MORRISON
Journal:  J Lab Clin Med       Date:  1960-06

3.  [Specific phyto-agglutinins of the ABO blood groups].

Authors:  P CAZAL; M LALAURIE
Journal:  Acta Haematol       Date:  1952 Jul-Aug       Impact factor: 2.195

4.  Neutralization of the anti-H agglutinin in eel serum by simple sugars.

Authors:  W M WATKINS; W T MORGAN
Journal:  Nature       Date:  1952-05-17       Impact factor: 49.962

5.  The reactivity of subunits of IgM anti-B.

Authors:  J Economidou; N C Hughes-Jones; B Gardner
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

6.  Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. 3. Binding of a labeled oligosaccharide derived from S8 by anti-S8 antibodies.

Authors:  A M Pappenheimer; W P Reed; R Brown
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

7.  Some products of the degradation of blood group substances by alkaline borohydride.

Authors:  K O Lloyd; E A Kabat
Journal:  Biochem Biophys Res Commun       Date:  1964-07-27       Impact factor: 3.575

8.  Immunochemical studies on blood groups. XXXIV. Structures of some oligosaccharides produced by alkaline degradation of blood group A, B, and H substances.

Authors:  K O Lloyd; E A Kabat; E J Layug; F Gruezo
Journal:  Biochemistry       Date:  1966-05       Impact factor: 3.162

9.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  Studies on human antibodies. IV. Purification and properties of anti-A and anti-B obtained by absorption and elution from insoluble blood group substances.

Authors:  M E Kaplan; E A Kabat
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  8 in total

1.  Binding of epithelial cells to lectin-coated surfaces.

Authors:  S G Phillips; S L Lui; D M Phillips
Journal:  In Vitro       Date:  1982-08

2.  Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.

Authors:  S Hammarström; E Engvall; B G Johansson; S Svensson; G Sundblad; I J Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  A versatile immunoadsorbent capable of binding lectins of various specificities and its use for the separation of cell populations.

Authors:  M E Pereira; E A Kabat
Journal:  J Cell Biol       Date:  1979-07       Impact factor: 10.539

4.  Immunochemical studies on blood groups. LI. A comparative study of the reaction of A 1 and A 2 blood group glycoproteins with human anti-A.

Authors:  C Moreno; A Lundblad; B A Kabat
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

5.  Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans.

Authors:  J Cisar; E A Kabat; J Liao; M Potter
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

6.  Immunochemical studies on blood groups LXII. Fractionation of hog and human A, H, and AH blood group active substance on insoluble immunoadsorbents of Dolichos and Lotus lectins.

Authors:  M E Pereira; E A Kabat
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

7.  Immunochemical studies on blood groups LXVI. Competitive binding assays of A1 and A2 blood group substances with insolubilized anti-A serum and insolubilized A agglutinin from Dolichos biflorus.

Authors:  E C Kisailus; E A Kabat
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran.

Authors:  J Cisar; E A Kabat; M M Dorner; J Liao
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.